Gordon & Doner Warns of FDAÂ’s Pradaxa Update

(LegalLaw247.com, December 05, 2012 ) WEST PALM BEACH, FL – The FDA’s recent announcement states that following their evaluation, Pradaxa users did not find a greater risk of bleeding when compared with the use of a related drug, warfarin. While this announcement was in fact accurate, the FDA failed to state that the drug warfarin includes a reversal agent to handle a situation where a bleeding emergency is arises. Pradaxa, conversely, does not include an antidote which would be vital for anticlotting and thus preventing severe and perhaps fatal bleeds. For more information, please visit: http://www.fortheinjured.com/.

Pradaxa works by inhibiting the enzyme responsible for blood clotting; however, in some instances, it works too well. When a patient who has been taking Pradaxa suffers a serious bleeding event, their blood fails to clot and can sometimes cause gastro-intestinal bleeds, resulting in hospitalization or the patient bleeding to death. In addition to the increased risk of internal bleeding, Pradaxa has also been linked to an increased risk of heart attack. Research has shown that Pradaxa patients with atrial fibrillation have a 38 percent higher risk of heart attack than patients who take similar anti-coagulants.

At this time, more than 100 lawsuits have been filed in regard to the adverse effects after use of the drug Pradaxa. If you or someone you love has suffered from internal bleeding after taking Pradaxa, you may be eligible to receive compensation for medical bills, lost wages, and pain and suffering.

About Gordon and Doner

Gordon and Doner is committed to helping all those who have been injured by the actions or negligence of another person or entity. The personal injury law firm based in West Palm Beach, Florida handles all types of personal injury claims including auto accident injuries, dangerous drug litigation, medical malpractice, product liability claims, premises liability and maritime law.

Gordon & Doner, PA
PMP Marketing Group
561-253-6712
pressrelease@pmpmg.com

Source: EmailWire.Com
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>